Inovio Pharmaceuticals
INO
#9180
Rank
ยฃ83.88 M
Marketcap
ยฃ1.21
Share price
3.87%
Change (1 day)
-9.20%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ58.14 Million

According to Inovio Pharmaceuticals's latest financial reports the company's total liabilities are ยฃ58.14 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Inovio Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ35.61 M-15.35%
2023-12-31ยฃ42.07 M-59.66%
2022-12-31ยฃ0.10 B46.23%
2021-12-31ยฃ71.32 M23.63%
2020-12-31ยฃ57.68 M-45.4%
2019-12-31ยฃ0.10 B204.25%
2018-12-31ยฃ34.72 M4.88%
2017-12-31ยฃ33.11 M-18.82%
2016-12-31ยฃ40.78 M59.45%
2015-12-31ยฃ25.58 M96.7%
2014-12-31ยฃ13 M-39.38%
2013-12-31ยฃ21.45 M237.23%
2012-12-31ยฃ6.36 M-25.35%
2011-12-31ยฃ8.52 M46.71%
2010-12-31ยฃ5.8 M-51.66%
2009-12-31ยฃ12.01 M-11.42%
2008-12-31ยฃ13.56 M208.32%
2007-12-31ยฃ4.39 M-30.77%
2006-12-31ยฃ6.35 M98.95%
2005-12-31ยฃ3.19 M13.52%
2004-12-31ยฃ2.81 M326.07%
2003-12-31ยฃ0.66 M-37.49%
2002-12-31ยฃ1.05 M-8.32%
2001-12-31ยฃ1.15 M
2001-03-31ยฃ1.12 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
ยฃ88.72 B 152,503.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ48.56 B 83,421.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ91.53 B 157,326.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ27.45 B 47,114.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ63.49 B 109,106.08%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ45.86 B 78,779.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
ยฃ0.78 B 1,250.72%๐Ÿ‡บ๐Ÿ‡ธ USA